A Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 24 May 2018
At a glance
- Drugs Docetaxel (Primary) ; Burixafor; Granulocyte colony-stimulating factors
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- 28 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 28 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated